BioNTech, founded by Turkish immigrants to Germany, and its US partner Pfizer on Tuesday announced starting of clinical study “to evaluate safety tolerability and immunogenicity of an Omicron-based vaccine candidate.” In a statement, the two companies announced the launching of a clinical study saying that it will be carried out on “healthy adults 18 through...
Tag: Pfizer
Post
Post
Fourth mRNA booster does not fully protect against omicron
The mRNA vaccine booster shots from Pfizer-BioNTech or Moderna are partially effective in defending against the Omicron variant of the coronavirus. They are safe and produce substantial antibodies, according to the preliminary results of research conducted by Sheba Medical Center in Israel. The trial showed that one week after people received the booster shot from...